Abzena
The Sr Manager, Bioconjugation Development leads scientific and technical teams in the end-to-end execution of bioconjugation process development programs, from early discovery to commercial manufacturing. This role involves coaching staff, managing customer relationships, and ensuring the successful scale-up and technology transfer of robust, reproducible bioconjugation processes. The position requires strong leadership in scientific strategy, documentation standards, and cross-functional collaboration within a CDMO environment.
Abzena is a fully integrated biopharmaceutical CDMO+CRO for antibodies, ADCs, AOCs, RDCs, vaccines, from discovery thru commercial.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Abzena.
Abzena didn’t post a salary, so this is our estimate from similar listings.
Scientific Director, Bioconjugation Development
lifelancer
Scientist, Bioconjugation
Dyne Therapeutics
Scientific Director, Bioconjugation Development
Neurocrine Biosciences
Scientist III - Bioconjugation (ADC) Process Development
Exelixis
Scientific/Sr Scientific Lead, Bioconjugation
Eli Lilly and Company
TEMP - Scientist, Bioconjugation Purification
Neurocrine Biosciences